- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01122576
Evaluation of 3 Intraocular Lenses Following Lens Extraction
February 12, 2014 updated by: Bausch & Lomb Incorporated
A Three Arm Prospective Clinical Evaluation of Three FDA Approved Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction.
The objective of this study is to evaluate the efficacy and subject satisfaction with three different FDA approved lenses for adults over 40 years of age who desire a reduction in spectacle dependence.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
78
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Aliso Viejo, California, United States, 92656
- Bausch & Lomb, Inc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects must have a clinically documented diagnosis of age-related bilateral cataracts that are considered amenable to treatment with standard phacoemulsification cataract extraction.
- Subjects must require a spherical lens power from 10.00 D to 33.00 D
- Subjects must have the potential for corrected distance visual acuity (CDVA) of 20/32 or better in both eyes, as documented by a Potential Acuity Meter
Exclusion Criteria:
- Subjects with conditions with increased risk of zonular rupture, such as pseudoexfoliation syndrome. Zonular rupture during cataract surgery may affect postoperative centration, tilt, and stability of the lens.
- Subjects who have any active inflammation or edema (swelling) of the cornea, including but not limited to the following: keratitis, keratoconjunctivitis, and keratouveitis.
- Subjects with visually significant diabetic retinopathy (proliferative or non-proliferative) which reduces potential acuity to 20/32 or worse.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Crystalens AO
Eligible subjects to undergo small incision cataract surgery and were implanted with the Crystalens AO bilaterally.
|
Crystalens AO surgically implanted bilaterally.
Study observation up to 180 days.
|
ACTIVE_COMPARATOR: ReSTOR
Eligible subjects to undergo small incision cataract surgery and were implanted with the ReSTOR IOL bilaterally.
|
ReSTOR surgically implanted bilaterally.
Study observation up to 180 days.
|
ACTIVE_COMPARATOR: Tecnis Multifocal IOL
Eligible subjects to undergo small incision cataract surgery and were implanted with the Tecnis Multifocal IOL bilaterally.
|
Tecnis surgically implanted bilaterally.
Study observation up to 180 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mesopic Monocular Contrast Sensitivity Without Glare 1.5 and 3 Cycles/Degree
Time Frame: Postoperative visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Postoperative visit 3 (2-3 months)
|
Mesopic Monocular Contrast Sensitivity Without Glare 6 Cycles/Degree
Time Frame: Postoperative visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Postoperative visit 3 (2-3 months)
|
Mesopic Monocular Contrast Sensitivity Without Glare 12 Cycles/Degree
Time Frame: Postoperative visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Postoperative visit 3 (2-3 months)
|
Mesopic Monocular Contrast Sensitivity Without Glare 18 Cycles/Degree
Time Frame: Postoperative visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Postoperative visit 3 (2-3 months)
|
Mesopic Monocular Contrast Sensitivity Without Glare 1.5 Cycles/Degree
Time Frame: Postoperative visit 4 ( 4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Postoperative visit 4 ( 4-6 months)
|
Mesopic Monocular Contrast Sensitivity Without Glare 3 Cycles/Degree
Time Frame: Postoperative visit 4 ( 4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Postoperative visit 4 ( 4-6 months)
|
Mesopic Monocular Contrast Sensitivity Without Glare 6 Cycles/Degree
Time Frame: Postoperative visit 4 ( 4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Postoperative visit 4 ( 4-6 months)
|
Mesopic Monocular Contrast Sensitivity Without Glare 12 Cycles/Degree
Time Frame: Postoperative visit 4 ( 4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Postoperative visit 4 ( 4-6 months)
|
Mesopic Monocular Contrast Sensitivity Without Glare 18 Cycles/Degree
Time Frame: Postoperative visit 4 ( 4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Postoperative visit 4 ( 4-6 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Binocular Mesopic Contrast Sensitivity Without Glare 1.5 & 3 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Binocular Mesopic Contrast Sensitivity Without Glare 6 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Binocular Mesopic Contrast Sensitivity Without Glare 12 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Binocular Mesopic Contrast Sensitivity Without Glare 18 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Binocular Mesopic Contrast Sensitivity Without Glare 1.5, 3, 6 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 4 (4-6 months)
|
Binocular Mesopic Contrast Sensitivity Without Glare 12 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 4 (4-6 months)
|
Binocular Mesopic Contrast Sensitivity Without Glare 18 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 4 (4-6 months)
|
Mesopic Monocular Contrast Sensitivity With Glare 1.5 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Mesopic Monocular Contrast Sensitivity With Glare 3 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Mesopic Monocular Contrast Sensitivity With Glare 6 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Mesopic Monocular Contrast Sensitivity With Glare 12 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Mesopic Monocular Contrast Sensitivity With Glare 18 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Mesopic Monocular Contrast Sensitivity With Glare 1.5 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 4 (4-6 months)
|
Mesopic Monocular Contrast Sensitivity With Glare 3 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 4 (4-6 months)
|
Mesopic Monocular Contrast Sensitivity With Glare 6 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 4 (4-6 months)
|
Mesopic Monocular Contrast Sensitivity With Glare 12 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 4 (4-6 months)
|
Mesopic Monocular Contrast Sensitivity With Glare 18 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 4 (4-6 months)
|
Mesopic Binocular Contrast Sensitivity With Glare 1.5, 3 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Mesopic Binocular Contrast Sensitivity With Glare 6 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Mesopic Binocular Contrast Sensitivity With Glare 12 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Mesopic Binocular Contrast Sensitivity With Glare 18 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 3 (2-3 months)
|
Mesopic Binocular Contrast Sensitivity With Glare 1.5, 3 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 4 (4-6 months)
|
Mesopic Binocular Contrast Sensitivity With Glare 6 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 4 (4-6 months)
|
Mesopic Binocular Contrast Sensitivity With Glare 12 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 4 (4-6 months)
|
Mesopic Binocular Contrast Sensitivity With Glare 18 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
|
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle).
A higher mean indicates improved contrast sensitivity
|
Visit 4 (4-6 months)
|
Optical Scatter
Time Frame: Visit 3 (2-3 months)
|
Objective scatter index (OSI) was assessed using the Optical Quality Analysis System(OQAS) and summarized as a continuous variable.
For this assessment, an OSI score of 1 or less represents good quality vision, 1-2 indicates some degradation but otherwise normal vision, 2-3 significant light scatter possibly requiring treatment, and scores over 4 severely compromised vision requiring intervention.
|
Visit 3 (2-3 months)
|
Optical Scatter
Time Frame: Visit 4 (4-6 months)
|
Objective scatter index (OSI) was assessed using the Optical Quality Analysis System(OQAS) and summarized as a continuous variable.
For this assessment, an OSI score of 1 or less represents good quality vision, 1-2 indicates some degradation but otherwise normal vision, 2-3 significant light scatter possibly requiring treatment, and scores over 4 severely compromised vision requiring intervention.
|
Visit 4 (4-6 months)
|
Monocular Halo and Starburst
Time Frame: Visit 3 (2-3 months)
|
Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome.
|
Visit 3 (2-3 months)
|
Monocular Halo and Starburst
Time Frame: Visit 4 (4-6 months)
|
Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome.
|
Visit 4 (4-6 months)
|
Binocular Halo and Starburst
Time Frame: Visit 3 (2-3 months)
|
Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome.
|
Visit 3 (2-3 months)
|
Binocular Halo and Starburst
Time Frame: Visit 4 (4-6 months)
|
Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome.
|
Visit 4 (4-6 months)
|
Manifest Refraction
Time Frame: Visit 3 (2-3 Months)
|
Manifest refraction spherical equivalent (MRSE) was calculated as the value of the sphere plus one-half of the value of the cylinder.
|
Visit 3 (2-3 Months)
|
Manifest Refraction
Time Frame: Visit 4 (4-6 Months)
|
Manifest refraction spherical equivalent (MRSE) was calculated as the value of the sphere plus one-half of the value of the cylinder.
|
Visit 4 (4-6 Months)
|
Uncorrected Distance Visual Acuity
Time Frame: Visit 3 (2-3 months) Visit 4 (4-6 months)
|
High Contrast Uncorrected Distance (UCDVA) measured at 32 inches, Intermediate (UCIVA) at 32 inches, and Near Visual Acuity (UCNVA) at 16 inches
|
Visit 3 (2-3 months) Visit 4 (4-6 months)
|
Best-corrected Distance Visual Acuity
Time Frame: Visit 3 (2-3 months) Visit 4 (4-6 months)
|
High Contrast Distance-Corrected Distance,(BCDVA), Intermediate (DCIVA), and Near Visual Acuity (DCNVA)
|
Visit 3 (2-3 months) Visit 4 (4-6 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Omid Khodai, OD, RAC, Bausch & Lomb Incorporated
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2010
Primary Completion (ACTUAL)
June 1, 2012
Study Completion (ACTUAL)
September 1, 2012
Study Registration Dates
First Submitted
May 11, 2010
First Submitted That Met QC Criteria
May 12, 2010
First Posted (ESTIMATE)
May 13, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
March 28, 2014
Last Update Submitted That Met QC Criteria
February 12, 2014
Last Verified
February 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 651 (CHM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingCataract ExtractionChina
Clinical Trials on Crystalens AO
-
Bausch & Lomb IncorporatedTerminated
-
Innovative MedicalCompletedAphakiaUnited States
-
Innovative MedicalCompletedTo Collect Information About Visual Outcomes and Participant SatisfactionUnited States
-
Bausch & Lomb IncorporatedCompleted
-
Mark Packer, MD, FACSAbbott Medical OpticsCompleted
-
Hospital Cruz Roja MexicanaUnknown
-
ActiveO Inc.CompletedDisk, HerniatedCanada
-
TherOxCompletedMyocardial InfarctionUnited States
-
A2A Pharmaceuticals Inc.RecruitingTriple Negative Breast Cancer | Endometrial Cancer | High Grade Serous Ovarian CancerUnited States